HB 1714 Summary

• Prohibits employers from discriminating against job applicants based on off-duty cannabis use or positive tests for nonpsychoactive cannabis metabolites during preemployment drug screening.

• Allows employers to use drug screening methods that do not detect nonpsychoactive cannabis metabolites and permits testing that includes cannabis as long as results are not disclosed to the employer.

• Exempts positions requiring federal background investigation, security clearance, airline/aerospace industry roles, and other safety-sensitive positions where impairment presents substantial risk of death.

• Does not preempt federal or state laws requiring drug testing as a condition of employment, federal funding, licensing benefits, or federal contracts, nor does it affect employer rights to maintain drug-free workplaces or conduct post-accident or suspicion-based testing.

• Becomes effective November 1, 2025.